Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 11.36 is 15% above its 1-year average of 9.85, near the high end of its 1-year range (8.33–11.36).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly current ratio; no daily interpolation.
Limited quarterly history available
Current Ratio needs at least three reported quarters before a meaningful chart is shown.
CURRENT RATIO
11.36
CURRENT RATIO AVG TTM
N/A
CURRENT RATIO AVG 3Y
N/A
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+202.96%
vs the sector median at left
Odyssey Therapeutics, Inc.
Market Cap
$882.10M
Current Ratio
11.36
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$880.85M
Current Ratio
16.16
TTM Avg
3.88
3Y Avg
3.97
5Y Avg
4.50
Market Cap
$882.99M
Current Ratio
81.42
TTM Avg
11.94
3Y Avg
8.59
5Y Avg
10.34
Market Cap
$863.59M
Current Ratio
1.95
TTM Avg
2.27
3Y Avg
2.05
5Y Avg
2.13
Market Cap
$857.96M
Current Ratio
3.05
TTM Avg
43.83
3Y Avg
35.58
5Y Avg
35.58
Market Cap
$849.50M
Current Ratio
4.92
TTM Avg
7.19
3Y Avg
6.36
5Y Avg
8.34
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Odyssey Therapeutics, Inc. (ODTX) | $882.10M | 11.36 | N/A | N/A | N/A |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $880.85M | 16.16 | 3.88 | 3.97 | 4.50 |
| Arbutus Biopharma Corp (ABUS)vs › | $882.99M | 81.42 | 11.94 | 8.59 | 10.34 |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $863.59M | 1.95 | 2.27 | 2.05 | 2.13 |
| Bioventus Inc. (BVS)vs › | $898.60M | 1.69 | 1.50 | 1.36 | 1.44 |
| SL Science Holding Ltd (SLBT)vs › | $857.96M | 3.05 | 43.83 | 35.58 | 35.58 |
| SI-BONE, Inc. (SIBN)vs › | $856.66M | 9.15 | 8.11 | 7.93 | 9.72 |
| HealthStream, Inc. (HSTM)vs › | $912.77M | 1.06 | 1.14 | 1.09 | 1.06 |
| Pacific Biosciences of California, Inc. (PACB)vs › | $849.50M | 4.92 | 7.19 | 6.36 | 8.34 |
| QuidelOrtho Corporation (QDEL)vs › | $846.74M | 1.39 | 1.36 | 1.46 | 2.28 |
Current Ratio
11.36
Quick Ratio
11.36
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 11.36 |
| 2026-03-31 | 8.33 |
